Our company has entered into an exclusive distribution agreement in the United States for peripheral guidewires with Medtronic (headquartered in Dublin, Ireland).
We anticipate that the introduction of the F-14 series (0.014 in) and F-18 series (0.018 in) will enhance treatment outcomes for patients across a wide range of indications.
For details, please refer to https://news.medtronic.com/Medtronic-first-in-the-U-S-to-offer-400-cm-0-018-peripheral-guidewire-for-transradial-access .
We are moving our headquarters and endeavor to use this opportunity to improve our services. Thank you for your continued support and encouragement.
FMD announces a strategic collaboration with Boston Scientific for the new line of Boston Scientific SENTAI™ coronary guidewires. The SENTAI family of wires, designed and manufactured by FMD in collaboration with Boston Scientific, includes 2 frontline workhorse wires (SAMURAI™ and MARVEL™), 5 specialty crossing wires (SAMURAI™ RC, FIGHTER™, HORNET™, HORNET™ 10, and HORNET™ 14) and 1 extension wire (STRETCH™). Boston Scientific has exclusive rights to market the SENTAI guidewires outside of Japan.
http://www.bostonscientific.com/en-US/products/guidewires/sentai-guidewires.html
Our website has been updated.
R&D Center attains ISO 13485: 2003 certification
R&D Center is completed in Aichi Prefecture
FMD attains ISO13485:2003 certification
Minimally invasive catheter therapy has taken the place of many surgical procedures in recent years. We perform research and development as well as the manufacturing of guidewires which are an indispensable part of minimally invasive catheter therapy. We passionately and untiringly pursue research and development in order to provide the best possible medial device for the patient.
FMD Co., Ltd. 1-57-7 Sasazuka, Shibuya-ku, Tokyo 151-0073 Japan info@fmd-j.com
Copyright © 2015 FMD All Rights Reserved